Venus Medtech Stock Technical Analysis

VMTHF Stock  USD 0.27  0.00  0.00%   
As of the 8th of February, Venus Medtech has the Variance of 1.66, risk adjusted performance of (0.12), and Coefficient Of Variation of (642.52). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Venus Medtech, as well as the relationship between them. Please validate Venus Medtech market risk adjusted performance, variance, as well as the relationship between the Variance and skewness to decide if Venus Medtech is priced more or less accurately, providing market reflects its prevalent price of 0.27 per share. As Venus Medtech appears to be a penny stock we also recommend to double-check its information ratio numbers.

Venus Medtech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Venus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Venus
  
Venus Medtech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Venus Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Venus Medtech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Venus Medtech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Venus Medtech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Venus Medtech.
0.00
11/10/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/08/2026
0.00
If you would invest  0.00  in Venus Medtech on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Venus Medtech or generate 0.0% return on investment in Venus Medtech over 90 days. Venus Medtech is related to or competes with Avita Medical, BICO Group, Cellink AB, 3-D Matrix, Paxman AB, Jushi Holdings, and Molecular Partners. Venus Medtech Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internati... More

Venus Medtech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Venus Medtech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Venus Medtech upside and downside potential and time the market with a certain degree of confidence.

Venus Medtech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Venus Medtech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Venus Medtech's standard deviation. In reality, there are many statistical measures that can use Venus Medtech historical prices to predict the future Venus Medtech's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.271.58
Details
Intrinsic
Valuation
LowRealHigh
0.010.241.55
Details
Naive
Forecast
LowNextHigh
0.010.261.57
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.250.280.30
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Venus Medtech. Your research has to be compared to or analyzed against Venus Medtech's peers to derive any actionable benefits. When done correctly, Venus Medtech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Venus Medtech.

Venus Medtech February 8, 2026 Technical Indicators

Venus Medtech Backtested Returns

Venus Medtech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16 % return per unit of risk over the last 3 months. Venus Medtech exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Venus Medtech's Risk Adjusted Performance of (0.12), coefficient of variation of (642.52), and Variance of 1.66 to confirm the risk estimate we provide. The entity has a beta of -0.16, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Venus Medtech are expected to decrease at a much lower rate. During the bear market, Venus Medtech is likely to outperform the market. At this point, Venus Medtech has a negative expected return of -0.2%. Please make sure to validate Venus Medtech's treynor ratio and rate of daily change , to decide if Venus Medtech performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Venus Medtech has no correlation between past and present. Overlapping area represents the amount of predictability between Venus Medtech time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Venus Medtech price movement. The serial correlation of 0.0 indicates that just 0.0% of current Venus Medtech price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.55
Residual Average0.0
Price Variance0.0
Venus Medtech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Venus Medtech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Venus Medtech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Venus Medtech Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Venus Medtech volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Venus Medtech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Venus Medtech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Venus Medtech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Venus Medtech price pattern first instead of the macroeconomic environment surrounding Venus Medtech. By analyzing Venus Medtech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Venus Medtech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Venus Medtech specific price patterns or momentum indicators. Please read more on our technical analysis page.

Venus Medtech February 8, 2026 Technical Indicators

Most technical analysis of Venus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Venus from various momentum indicators to cycle indicators. When you analyze Venus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Venus Medtech February 8, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Venus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Venus Pink Sheet analysis

When running Venus Medtech's price analysis, check to measure Venus Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Venus Medtech is operating at the current time. Most of Venus Medtech's value examination focuses on studying past and present price action to predict the probability of Venus Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Venus Medtech's price. Additionally, you may evaluate how the addition of Venus Medtech to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume